Clinical trial NIS-OBE-CAP-2013/1
Caprelsa(r) Registry : A Belgian Registry to evaluate the use of Vandetanib (Caprelsa(r)) in current clinical practice
| Cancers | |
|---|---|
| Organ | Thyroïd |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Prospective observational study
|
| Academic trial | Non |
| Sponsor | AstraZeneca |
| BECT Identifier | B143201420005 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02109250 |
| Inclusion criteria | Already received a prescription for vandeanib |
| Last update |